haku: @journal_id 1668 / yhteensä: 273
viitteet: 155-164 / 273
« edellinen sivu | seuraava sivu »
 otsikkovuositekijä
155.
Advertising and alcohol consumption in the UK
International Journal of Advertising
2004 : VOL. 23:2, p. 149-171
 2004 Dorsett, J.
Dickerson, S.
156.
Pharmaceutical advertising in the USA: information or influence?
International Journal of Advertising
2004 : VOL. 23:1, p. 119-142
 2004 Main, K.J.
Argo, J.J.
Huhmann, B.A.
157.
A model assessing the effectiveness of direct-to-consumer advertising: integration of concepts and measures from marketing and healthcare
International Journal of Advertising
2004 : VOL. 23:1, p. 91-118
 2004 Menon, A.M. (et al.)
158.
Prescription medication advertising: professional discomfort and potential patient benefits - can the two be balanced?
International Journal of Advertising
2004 : VOL. 23:1, p. 69-90
 2004 Eagle, L.
Chamberlain, K.
159.
"Ask your doctor!" Measuring the effect of direct-to-consumer communications in the world's largest healthcare market
International Journal of Advertising
2004 : VOL. 23:1, p. 53-68
 2004 White H.J. (et al.),
160.
The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debate
International Journal of Advertising
2004 : VOL. 23:1, p. 5-52
 2004 Auton, F.
161.
Reframing replicative research in advertising
International Journal of Advertising
2003 : VOL 22, p. 511-530
 2003 Berthon, P. (et. al)
162.
A reply to the comment of Franke and Andrews on "The economics of tobacco advertising: spending, demand and the effects of bans"
International Journal of Advertising
2003 : VOL 22:4, p. 469-485
 2003 Lancaster, K.
Lancaster, A.
163.
Comment on "The economics of tobacco advertising: spending, demand, and the effects of bans"
International Journal of Advertising
2003 : VOL 22:4, p. 461-468
 2003 Franke, G.
Andrews, R.
164.
Can recipients of sales flyers be segmented?
International Journal of Advertising
2003 : VOL. 22:3, p. 375-391
 2003 Schmidt, M.
Bjerre, M.
« edellinen sivu | seuraava sivu »
SCIMA